journal
https://read.qxmd.com/read/38661130/myocarditis-in-children-2024-new-themes-and-continued-questions
#1
JOURNAL ARTICLE
Jason F Goldberg, Joseph A Spinner, Jonathan H Soslow
PURPOSE: While pediatric myocarditis incidence has increased since the coronavirus disease 2019 (COVID-19) pandemic, there remain questions regarding diagnosis, risk stratification, and optimal therapy. This review highlights recent publications and continued unanswered questions related to myocarditis in children. RECENT FINDINGS: Emergence from the COVID-19 era has allowed more accurate description of the incidence and prognosis of myocarditis adjacent to COVID-19 infection and vaccine administration as well that of multi-system inflammatory disease in children (MIS-C)...
April 25, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38652263/treatment-of-transthyretin-cardiac-amyloidosis
#2
JOURNAL ARTICLE
Dimitrios Bampatsias, Abdirahman Wardhere, Mathew S Maurer
PURPOSE OF REVIEW: Tafamidis is currently the only approved disease-modifying treatment for ATTR-CM. However, there have been important developments in the treatment of ATTR-CM, as the results of two phase 3 trials were published and several other trials are in their final stages. In this review, we summarize current and future therapies for ATTR-CM. RECENT FINDINGS: Recently, acoramidis, a TTR stabilizer has been proven to be effective in reducing mortality and morbidity compared to placebo in the ATTRibute-CM trial...
April 22, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38652248/genetic-aortopathies-a-case-based-approach-to-multidisciplinary-program-development
#3
JOURNAL ARTICLE
Christopher P Jordan, Akos Berthold, Jason Bonomo
PURPOSE OF REVIEW: The incorporation of genetic counseling and testing is essential to evaluation and management of thoracic aortic disease in patients under 60 years of age and those with family histories suspicious for heritable thoracic aortic disease and disorders associated with increased risk for acute type-A aortic dissection. RECENT FINDINGS: As many as 20% of individuals with thoracic aortic disease under the age of 60 years have autosomal dominant patterns of inheritance...
April 22, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38652290/recent-advances-in-multimodal-imaging-in-tetralogy-of-fallot-and-double-outlet-right-ventricle
#4
JOURNAL ARTICLE
Aakansha Ajay Vir Singh, Shi-Joon Yoo, Mike Seed, Christopher Z Lam, Israel Valverde
PURPOSE OF REVIEW: In the ever-evolving field of medical imaging, this review highlights significant advancements in preoperative and postoperative imaging for Tetralogy of Fallot (TOF) and double outlet right ventricle (DORV) over the past 18 months. RECENT FINDINGS: This review showcases innovations in echocardiography such as 3D speckle tracking echocardiography (3DSTE) for assessing right ventricle-pulmonary artery coupling (RVPAC) and Doppler velocity reconstruction (DoVeR) for intracardiac flow fields evaluation...
April 17, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38606680/mitral-annular-disjunction-and-mitral-valve-prolapse-extrapolating-adult-data-to-an-adolescent-cohort
#5
JOURNAL ARTICLE
Mitchell I Cohen, Melany B Atkins, Christopher P Jordan
PURPOSE OF REVIEW: The aim of this study is to provide an update on mitral valve prolapse (MVP) and mitral annular disjunction (MAD) and who may be at risk for ventricular arrhythmias and sudden cardiac death. RECENT FINDINGS: MVP is generally considered a benign condition. However, a small subset of patients may be at risk for life-threatening ventricular arrhythmias. Among the risk factors identified in adults include patients with bileaflet mitral valves, myxomatous changes, myocardial fibrosis, and the presence of MAD...
April 9, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38606679/closing-the-care-gap-combining-enhanced-recovery-with-minimally-invasive-valve-surgery
#6
JOURNAL ARTICLE
Alexander J Gregory, William D T Kent, Corey Adams, Rakesh C Arora
PURPOSE OF REVIEW: Patients with advanced age and frailty require interventions for structural heart disease at an increasing rate. These patients typically experience higher rates of postoperative morbidity, mortality and prolonged hospital length of stay, loss of independence as well as associated increased costs to the healthcare system. Therefore, it is becoming critically important to raise awareness and develop strategies to improve clinical outcomes in the contemporary, high-risk patient population undergoing cardiacprocedures...
April 9, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38606626/epigenetic-regulation-of-heart-failure
#7
JOURNAL ARTICLE
Manisha Deogharia, Priyatansh Gurha
PURPOSE OF REVIEW: The studies on chromatin-modifying enzymes and how they respond to different stimuli within the cell have revolutionized our understanding of epigenetics. In this review, we provide an overview of the recent studies on epigenetic mechanisms implicated in heart failure. RECENT FINDINGS: We focus on the major mechanisms and the conceptual advances in epigenetics as evidenced by studies in humans and mouse models of heart failure. The significance of epigenetic modifications and the enzymes that catalyze them is also discussed...
April 8, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38606620/no-touch-saphenous-vein-current-understanding-of-the-conduit-less-handled
#8
JOURNAL ARTICLE
Mimi X Deng, Grace S Lee, Dominique Vervoort, Stephen E Fremes
PURPOSE OF REVIEW: The no-touch technique is an established method to harvest the saphenous vein (NT-SV), which is the most commonly used conduit in coronary artery bypass grafting. Herein, we summarize the foundational evidence, as well as highlight recent innovations and ongoing clinical trials involving NT-SV. RECENT FINDINGS: Through preservation of perivascular tissue for atraumatic handling and omission of manual distension, the NT-SV maintains endothelial nitrous oxide synthase levels and experiences less vascular smooth muscle cell activation, which translates to slower progression of atherosclerosis and less size mismatch of the graft and target vessel...
April 5, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38567924/controversies-related-to-renal-artery-denervation-and-devices
#9
JOURNAL ARTICLE
Chibuike Charles Agwuegbo, Akanimo Usen Antia, Garba Rimamskep Shamaki, Tamunoinemi Bob-Manuel
PURPOSE OF REVIEW: This review article discusses the controversies, strengths, and limitations of the current literature on renal artery denervation in the management of resistant hypertension, as well as the future directions of this intervention. RECENT FINDINGS: There have been conflicting data from the different randomized control trials assessing the efficacy of renal artery denervation in the management of resistant hypertension. SUMMARY: Renal artery denervation is achieved by ablating the sympathetic nerves surrounding the renal arteries using endovascular ultrasound, radiofrequency, or alcohol...
April 4, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38547158/management-of-hypertension-in-heart-transplant-recipients-an-ongoing-conundrum
#10
JOURNAL ARTICLE
Juan Duarte Torres, Selim R Krim
PURPOSE OF REVIEW: Hypertension remains one of the most common clinical problems leading to significant posttransplant complications. This study reviews the pathophysiology of hypertension in the postcardiac transplant phase and provides an update on currently available antihypertensive therapies for heart transplant patients. RECENT FINDINGS: The true prevalence of hypertension in the heart transplant population remains unknown. Effective blood pressure (BP) control is key to prevent left ventricular remodeling, diastolic dysfunction and stroke...
March 28, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38547148/recent-updates-on-therapeutic-targeting-of-lipoprotein-a-with-rna-interference
#11
JOURNAL ARTICLE
Aravind Sekhar, Ashani Kuttan, Richard A Lange
PURPOSE: RNA interference (RNAi)-based therapies that target specific gene products have impacted clinical medicine with 16 FDA approved drugs. RNAi therapy focused on reducing plasma lipoprotein(a) [Lp(a)] levels are under evaluation. FINDINGS: RNAi-based therapies have made significant progress over the past 2 decades and currently consist of antisense oligonucleotides (ASO) and small interfering RNA (siRNA). Chemical modification of the RNA backbone and conjugation of siRNA enables efficient gene silencing in hepatocytes allowing development of effective cholesterol lowering therapies...
March 27, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38547042/high-reliability-pediatric-heart-centers-always-working-toward-getting-better
#12
JOURNAL ARTICLE
Andrea Torzone, Alexandra Birely
PURPOSE OF REVIEW: The purpose of this review is to examine high reliability through the lens of a contemporary pediatric heart center, noting that continuous improvement, rather than perfection, should be embraced. Aiming to elevate topics with lesser attention, this review elaborates on key concepts and proposed considerations for maintaining a high reliability heart center. RECENT FINDINGS: As provision of care reaches a new complexity, programs are called upon to evaluate how they can bring their teams into the future of pediatric cardiac care...
March 27, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38547019/bad-behavior-in-healthcare-an-insidious-threat-to-patients-staff-and-organizations
#13
JOURNAL ARTICLE
Liz Crowe, Christine M Riley
PURPOSE OF REVIEW: 'Bad' or unprofessional behavior (UPB) destroys communication, teamwork, and professional wellbeing, presenting a significant threat to patients and staff. Understanding what constitutes 'bad' or UPB and creating broad accountability for its cessation is imperative to patient-centered care and the survival of the multidisciplinary health workforce. RECENT FINDINGS: Despite organizational and legislative commitments to provide well tolerated work environments, UPB is endemic in healthcare and continues to harm patients, staff, and organizations...
March 21, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38483006/genetic-causes-of-lymphatic-disorders-recent-updates-on-the-clinical-and-molecular-aspects-of-lymphatic-disease
#14
JOURNAL ARTICLE
Catharine Bowman, Stanley G Rockson
PURPOSE OF REVIEW: The lymphatic system facilitates several key functions that limit significant morbidity and mortality. Despite the impact and burden of lymphatic disorders, there are many remaining disorders whose genetic substrate remains unknown. The purpose of this review is to provide an update on the genetic causes of lymphatic disorders, while reporting on newly proposed clinical classifications of lymphatic disease. RECENT FINDINGS: We reviewed several new mutations in genes that have been identified as potential causes of lymphatic disorders including: MDFIC, EPHB4, and ANGPT2...
March 14, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38482858/leaders-need-to-look-in-the-mirror
#15
JOURNAL ARTICLE
Josh Koch
PURPOSE OF REVIEW: There is commonly a discrepancy between optimal physician leader behavior and actual physician leader behavior. Identifying and addressing this discrepancy is essential to optimize culture in high-risk care units. RECENT FINDINGS: Unit culture is directly linked to improving well tolerated and effective care. Adoption of strategies to better address bad behavior is necessary. SUMMARY: To address a toxic culture in a high-risk unit, physician leaders must first look inwards and take personal responsibility for their actions and words...
March 12, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38456429/predictive-utility-of-remnant-cholesterol-in-atherosclerotic-cardiovascular-disease
#16
JOURNAL ARTICLE
Spencer D Proctor, Maggie Wang, Donna F Vine, Paolo Raggi
PURPOSE OF REVIEW: Remnant cholesterol (RC) is the cholesterol carried in lipoproteins derived from the catabolism of chylomicrons and very low-density lipoproteins. Evidence supporting the causal relationship of RC with atherosclerotic cardiovascular disease (ASVD) is accumulating rapidly. The number of impactful contributions to this field are increasing and provide a pathophysiological insight into the current residual cardiovascular risk beyond low-density cholesterol (LDL)-cholesterol (LDL-C)...
March 11, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38482842/pemafibrate-and-other-triglyceride-lowering-therapies-to-reduce-risk-of-cardiovascular-and-metabolic-disease
#17
JOURNAL ARTICLE
Michael Miller
PURPOSE OF REVIEW: Although high triglycerides are consistently associated with elevated risk of cardiovascular disease (CVD), therapies that reduce triglyceride levels have inconsistently translated into reduced CVD risk. RECENT FINDINGS: To date, three clinical trials have tested triglyceride-lowering therapies in patients with hypertriglyceridemia (HTG) and elevated risk of incident/recurrent CVD. In REDUCE-IT (Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial), assignment to IPE, a highly purified eicosapentanoic acid (EPA), resulted in a 25% reduction in nonfatal myocardial infarction), nonfatal stroke, cardiovascular death, coronary revascularization and hospitalization for unstable angina...
March 6, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38603529/prevention-and-treatment-of-hypertensive-left-ventricular-hypertrophy
#18
JOURNAL ARTICLE
Manvita Tatavarthy, John Stathopoulos, Ahmet Afşin Oktay
PURPOSE OF REVIEW: Left ventricular (LV) hypertrophy (LVH) is a well recognized target organ adaptation to longstanding uncontrolled hypertension and other cardiovascular risk factors. It is also a strong and independent predictor of many cardiovascular disorders. RECENT FINDINGS: This focused review explores the current concepts in screening, diagnosis, prevention, and treatment of LVH in patients with hypertension. Currently, the primary screening and diagnostic tools for LVH are ECG and 2D echocardiography...
March 5, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38456513/resistant-hypertension
#19
JOURNAL ARTICLE
Farnoosh Shariati, Nitin Tandan, Carl J Lavie
PURPOSE OF REVIEW: Resistant hypertension (RH) is characterized by persistently elevated blood pressure despite the concurrent use of three antihypertensive medications, including a diuretic, at optimal doses. This clinical phenomenon poses a significant burden on healthcare systems worldwide due to its association with increased cardiovascular disease morbidity and mortality. RECENT FINDINGS: Ongoing studies on device-based treatment of RH, with aim to reduce sympathetic nervous system outflow, have shown promising evidence in management of RH which may in turn decrease the incidence of composite cardiovascular outcome faced by the affected population...
March 5, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38456474/effects-of-bempedoic-acid-on-markers-of-inflammation-and-lp-a
#20
JOURNAL ARTICLE
Sukhila Reddy, Abhizith Deoker
PURPOSE OF REVIEW: To study the effect of bempedoic acid on markers of inflammation and lipoprotein (a) to help determine if the drug would be useful to treat patients with elevated cardiovascular risks and residual cardiovascular risk despite optimal low-density lipoprotein cholesterol (LDL-C) levels. RECENT FINDINGS: Bempedoic acid is found to cause significant reduction in LDL-C and high-sensitivity C-reactive protein (hs-CRP) in various randomized clinical trials...
March 5, 2024: Current Opinion in Cardiology
journal
journal
29307
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.